XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue:    
Revenue $ 109,110 $ 70,933
Cost of sales 38,685 21,717
Gross profit 70,425 49,216
Operating expenses:    
Research and development 13,260 9,722
Sales, general and administrative 91,262 69,471
Litigation-related expenses 3,192 7,532
Amortization of acquired intangible assets 2,883 2,230
Transaction-related expenses   120
Restructuring expenses 175 1,370
Total operating expenses 110,772 90,445
Operating loss (40,347) (41,229)
Interest and other expense, net:    
Interest expense, net (3,874) (1,456)
Other income (expense), net 706 (30)
Total interest and other expense, net (3,168) (1,486)
Net loss before taxes (43,515) (42,715)
Income tax provision (benefit) 14 (99)
Net loss $ (43,529) $ (42,616)
Net loss per share, basic $ (0.40) $ (0.43)
Net loss per share, diluted $ (0.40) $ (0.43)
Weighted average shares outstanding, basic 109,751 99,978
Weighted average shares outstanding, diluted 109,751 99,978
Products and Services    
Revenue:    
Revenue $ 109,110 $ 70,918
International Supply Agreement    
Revenue:    
Revenue   $ 15